Benzinga's Top Downgrades

Analysts at JP Morgan downgraded Esperion Therapeutics Inc ESPR from Overweight to Neutral. The price target for Esperion Therapeutics has been lowered from $50 to $15. Esperion Therapeutics shares fell 32.51 percent to $10.92 in pre-market trading.
Analysts at Wells Fargo downgraded HeartWare International Inc HTWR from Outperform to Market Perform. Heartware shares closed at $57.55 on Tuesday.
Goldman Sachs downgraded PBF Energy Inc PBF from Buy to Neutral. The price target for PBF Energy has been lowered from $37 to $26. PBF Energy shares slipped 0.04 percent to $23.28 in pre-market trading.
Analysts at Bank of America downgraded Lincoln National Corporation LNC from Buy to Neutral. Lincoln National shares rose 0.33 percent to $36.89 in pre-market trading.
Susquehanna downgraded COMSCORE, Inc. SCOR from Positive to Neutral. comScore shares closed at $23.83 on Tuesday.
Evercore ISI Group downgraded Oceaneering International OII from Buy to Hold. Oceaneering International shares closed at $28.62 on Tuesday.
RBC Capital downgraded Metaldyne Performance Group Inc MPG from Outperform to Sector Perform. Metaldyne Performance Group shares closed at $13.62 on Tuesday.
Bank of America downgraded Principal Financial Group Inc PFG from Buy to Neutral. Principal Financial shares gained 0.10 percent to $39.10 in pre-market trading.
Analysts at Barclays downgraded AEGON N.V. (ADR) AEG from Equal-weight to Underweight. Aegon shares fell 1.98 percent to $3.96 in pre-market trading.